293 filings
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
1 Apr 24
Regulation FD Disclosure
8:00am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
12 Feb 24
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
8:00am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
8 Jan 24
Departure of Directors or Certain Officers
7:30am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
15 Dec 23
Changes in Registrant's Certifying Accountant
7:30am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
13 Nov 23
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
12:00am
8-K
guv10n
23 Oct 23
Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial
4:30pm
8-K
hfz ynqth
11 Oct 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
6xiyohef3yah
26 Sep 23
Acasti Announces $7.5 Million Private Placement Equity Financing
8:10am
8-K
frbljgj mmof2bf4nha8
11 Aug 23
Acasti Announces First Quarter 2024 Financial Results and Business Highlights
7:31am
8-K
w61f12nskuo
24 Jul 23
Other Events
5:30pm
8-K
2dcdkry
7 Jul 23
Acasti Pharma Announces 1-for-6 Reverse Stock Split
8:30am
8-K
zvykp
5 Jul 23
Other Events
4:00pm
8-K
zy8pq3flpq4u7zu299
23 Jun 23
Acasti Pharma Reports Fiscal Year 2023 Operational Results
7:31am
8-K
dpktz68n2btf0klqq7c
11 May 23
Departure of Directors or Certain Officers
4:50pm
8-K
6lf29n9koesfusf
5 Apr 23
Acasti Announces Appointment of Prashant Kohli as CEO
5:00pm
8-K
80y3kh
31 Mar 23
Departure of Directors or Certain Officers
4:39pm
8-K
v6dgz
13 Mar 23
Acasti Pharma Inc. Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture Exchange
8:04am
8-K
cy89y
22 Feb 23
Changes in Registrant's Certifying Accountant
6:15pm
8-K
bl938ab
14 Feb 23
Acasti Pharma Reports Third Quarter 2023 Operational Results
7:23am
8-K
frm yvv8p8xbjm
25 Jan 23
Other Events
4:10pm